Our drug discovery group specializes in cancer and central nervous system drug research. Several major products including Taxol have been discovered at RTI, and we currently have several compounds in clinical trials.
We have expertise in pharmacology, synthetic chemistry, modeling, analytical, and identification techniques. Our extensive laboratory facilities give us the ability to conduct multiple projects in support of our clients' drug discovery programs.
Our staff of principal investigators are highly skilled and experienced in the following areas of drug discovery:
- Chemical synthesis and characterization
Camptothecins, cannabinoids, morphans, phenylamines, steroids, tropanes
- Pharmacology and bioassays
Central nervous system pharmacology, cystic fibrosis, molecular biology
Electronic databases describing the chemistry, biology, and effects of compounds from more than 40 years of synthetic and natural products chemistry at RTI
- Traditional, rational drug design methodologies
- Combinatorial/array methodologies
- Nuclear magnetic resonance
- Array synthesis